COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - FRA:CBHD - DK0060448595 - Common Stock
76.56 EUR
+1.46 (+1.94%)
Taking everything into account, CBHD scores 5 out of 10 in our fundamental rating. CBHD was compared to 63 industry peers in the Health Care Equipment & Supplies industry. CBHD has an excellent profitability rating, but there are concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
In the past year CBHD had a positive cash flow from operations.
In the past 5 years CBHD has always been profitable.
CBHD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CBHD's Return On Assets of 8.51% is amongst the best of the industry. CBHD outperforms 84.13% of its industry peers.
Looking at the Return On Equity, with a value of 24.78%, CBHD belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
CBHD has a Return On Invested Capital of 15.96%. This is amongst the best in the industry. CBHD outperforms 95.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is significantly above the industry average of 9.52%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROIC | 15.96% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
CBHD has a Profit Margin of 14.62%. This is amongst the best in the industry. CBHD outperforms 84.13% of its industry peers.
CBHD's Profit Margin has declined in the last couple of years.
CBHD has a Operating Margin of 26.99%. This is amongst the best in the industry. CBHD outperforms 92.06% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
CBHD has a Gross Margin of 67.55%. This is in the better half of the industry: CBHD outperforms 74.60% of its industry peers.
In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
CBHD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CBHD has been increased compared to 5 years ago.
Compared to 1 year ago, CBHD has a worse debt to assets ratio.
2.2 Solvency
CBHD has an Altman-Z score of 3.84. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.84, CBHD is doing good in the industry, outperforming 66.67% of the companies in the same industry.
CBHD has a debt to FCF ratio of 4.89. This is a neutral value as CBHD would need 4.89 years to pay back of all of its debts.
CBHD has a Debt to FCF ratio (4.89) which is comparable to the rest of the industry.
CBHD has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.05, CBHD is doing worse than 82.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Altman-Z | 3.84 |
ROIC/WACC2.47
WACC6.46%
2.3 Liquidity
CBHD has a Current Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a Current ratio of 1.00. This is in the lower half of the industry: CBHD underperforms 74.60% of its industry peers.
CBHD has a Quick Ratio of 1.00. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
CBHD has a worse Quick ratio (0.64) than 79.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -13.94% in the last year.
Measured over the past 5 years, CBHD shows a small growth in Earnings Per Share. The EPS has been growing by 2.72% on average per year.
The Revenue has been growing slightly by 5.95% in the past year.
Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.54% on average per year.
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
3.2 Future
The Earnings Per Share is expected to grow by 10.04% on average over the next years. This is quite good.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 6.65% on average per year.
EPS Next Y-2.42%
EPS Next 2Y7.9%
EPS Next 3Y9%
EPS Next 5Y10.04%
Revenue Next Year3.9%
Revenue Next 2Y4.92%
Revenue Next 3Y5.76%
Revenue Next 5Y6.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CBHD is valuated quite expensively with a Price/Earnings ratio of 30.02.
Based on the Price/Earnings ratio, CBHD is valued a bit cheaper than 61.90% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.35, CBHD is valued at the same level.
With a Price/Forward Earnings ratio of 21.86, CBHD is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CBHD is valued a bit cheaper than the industry average as 60.32% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, CBHD is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.02 | ||
| Fwd PE | 21.86 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 60.32% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.29 | ||
| EV/EBITDA | 15.94 |
4.3 Compensation for Growth
The excellent profitability rating of CBHD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)11.04
EPS Next 2Y7.9%
EPS Next 3Y9%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.82%, CBHD has a reasonable but not impressive dividend return.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.09. CBHD pays more dividend than 95.24% of the companies in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.82% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
121.67% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP121.67%
EPS Next 2Y7.9%
EPS Next 3Y9%
FRA:CBHD (10/13/2025, 7:00:00 PM)
76.56
+1.46 (+1.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.09B
Analysts67.69
Price Target94.51 (23.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.82% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP121.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.87%
Min EPS beat(2)-22.36%
Max EPS beat(2)-15.38%
EPS beat(4)0
Avg EPS beat(4)-13.35%
Min EPS beat(4)-22.36%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-10.21%
EPS beat(12)0
Avg EPS beat(12)-8.91%
EPS beat(16)1
Avg EPS beat(16)-7.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-1.52%
Revenue beat(12)1
Avg Revenue beat(12)-1.36%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)-1.6%
PT rev (3m)-6.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.08%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)-14.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.95%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-1.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.02 | ||
| Fwd PE | 21.86 | ||
| P/S | 4.31 | ||
| P/FCF | 24.29 | ||
| P/OCF | 18.69 | ||
| P/B | 7.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.94 |
EPS(TTM)2.55
EY3.33%
EPS(NY)3.5
Fwd EY4.57%
FCF(TTM)3.15
FCFY4.12%
OCF(TTM)4.1
OCFY5.35%
SpS17.75
BVpS10.48
TBVpS-8.58
PEG (NY)N/A
PEG (5Y)11.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROCE | 20.15% | ||
| ROIC | 15.96% | ||
| ROICexc | 16.27% | ||
| ROICexgc | 89.1% | ||
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% | ||
| FCFM | 17.76% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexcg growth 3Y7.74%
ROICexcg growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Debt/EBITDA | 1.95 | ||
| Cap/Depr | 109.63% | ||
| Cap/Sales | 5.31% | ||
| Interest Coverage | 7.46 | ||
| Cash Conversion | 72.46% | ||
| Profit Quality | 121.42% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 3.84 |
F-Score6
WACC6.46%
ROIC/WACC2.47
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
EPS Next Y-2.42%
EPS Next 2Y7.9%
EPS Next 3Y9%
EPS Next 5Y10.04%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
Revenue Next Year3.9%
Revenue Next 2Y4.92%
Revenue Next 3Y5.76%
Revenue Next 5Y6.65%
EBIT growth 1Y4.5%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year22.79%
EBIT Next 3Y12.78%
EBIT Next 5Y11.59%
FCF growth 1Y53.38%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y43.32%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%